Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Targeting of prion-infected lymphoid cells to the central nervous system accelerates prion infection.

Friedman-Levi Y, Hoftberger R, Budka H, Mayer-Sonnenfeld T, Abramsky O, Ovadia H, Gabizon R.

J Neuroinflammation. 2012 Mar 21;9:58. doi: 10.1186/1742-2094-9-58.

2.

Exacerbation of experimental autoimmune encephalomyelitis in prion protein (PrPc)-null mice: evidence for a critical role of the central nervous system.

Gourdain P, Ballerini C, Nicot AB, Carnaud C.

J Neuroinflammation. 2012 Jan 26;9:25. doi: 10.1186/1742-2094-9-25.

3.

Fatal neurological disease in scrapie-infected mice induced for experimental autoimmune encephalomyelitis.

Friedman-Levi Y, Ovadia H, Hoftberger R, Einstein O, Abramsky O, Budka H, Gabizon R.

J Virol. 2007 Sep;81(18):9942-9. Epub 2007 Jul 11.

4.

Persistent retroviral infection with MoMuLV influences neuropathological signature and phenotype of prion disease.

Krasemann S, Neumann M, Luepke JP, Grashorn J, Wurr S, Stocking C, Glatzel M.

Acta Neuropathol. 2012 Jul;124(1):111-26. doi: 10.1007/s00401-012-0944-1. Epub 2012 Jan 24.

PMID:
22271154
5.

Complete Freund's adjuvant immunization prolongs survival in experimental prion disease in mice.

Tal Y, Souan L, Cohen IR, Meiner Z, Taraboulos A, Mor F.

J Neurosci Res. 2003 Jan 15;71(2):286-90.

PMID:
12503092
6.

Genetic prion disease: no role for the immune system in disease pathogenesis?

Friedman-Levi Y, Binyamin O, Frid K, Ovadia H, Gabizon R.

Hum Mol Genet. 2014 Aug 1;23(15):4134-41. doi: 10.1093/hmg/ddu134. Epub 2014 Mar 25. Erratum in: Hum Mol Genet. 2014 Nov 15;23(22):6138.

PMID:
24667414
7.

Subclinical prion disease induced by oral inoculation.

Thackray AM, Klein MA, Bujdoso R.

J Virol. 2003 Jul;77(14):7991-8.

8.

Prolongation of prion disease-associated symptomatic phase relates to CD3+ T cell recruitment into the CNS in murine scrapie-infected mice.

Sacquin A, Chaigneau T, Defaweux V, Adam M, Schneider B, Bruley Rosset M, Eloit M.

Brain Behav Immun. 2012 Aug;26(6):919-30. doi: 10.1016/j.bbi.2012.04.002. Epub 2012 Apr 13.

9.

The pathogenic mechanisms of prion diseases.

Unterberger U, Voigtländer T.

CNS Neurol Disord Drug Targets. 2007 Dec;6(6):424-55. Review.

PMID:
18220781
10.

The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity.

Hetz C, Russelakis-Carneiro M, Wälchli S, Carboni S, Vial-Knecht E, Maundrell K, Castilla J, Soto C.

J Neurosci. 2005 Mar 16;25(11):2793-802.

11.

Protease-sensitive prion species in neoplastic spleens of prion-infected mice with uncoupling of PrP(Sc) and prion infectivity.

Krasemann S, Neumann M, Szalay B, Stocking C, Glatzel M.

J Gen Virol. 2013 Feb;94(Pt 2):453-63. doi: 10.1099/vir.0.045922-0. Epub 2012 Nov 7.

PMID:
23136363
13.

Chemically induced accumulation of GAGs delays PrP(Sc) clearance but prolongs prion disease incubation time.

Mayer-Sonnenfeld T, Avrahami D, Friedman-Levi Y, Gabizon R.

Cell Mol Neurobiol. 2008 Nov;28(7):1005-15. doi: 10.1007/s10571-008-9274-1. Epub 2008 Mar 19.

PMID:
18350378
14.

Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.

Hucke S, Floßdorf J, Grützke B, Dunay IR, Frenzel K, Jungverdorben J, Linnartz B, Mack M, Peitz M, Brüstle O, Kurts C, Klockgether T, Neumann H, Prinz M, Wiendl H, Knolle P, Klotz L.

Brain. 2012 May;135(Pt 5):1586-605. doi: 10.1093/brain/aws058. Epub 2012 Mar 24.

PMID:
22447120
15.

The tyrosine kinase inhibitor imatinib mesylate delays prion neuroinvasion by inhibiting prion propagation in the periphery.

Yun SW, Ertmer A, Flechsig E, Gilch S, Riederer P, Gerlach M, Schätzl HM, Klein MA.

J Neurovirol. 2007 Aug;13(4):328-37.

PMID:
17849316
16.

Crucial role for prion protein membrane anchoring in the neuroinvasion and neural spread of prion infection.

Klingeborn M, Race B, Meade-White KD, Rosenke R, Striebel JF, Chesebro B.

J Virol. 2011 Feb;85(4):1484-94. doi: 10.1128/JVI.02167-10. Epub 2010 Dec 1.

17.

Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring.

Chesebro B, Race B, Meade-White K, Lacasse R, Race R, Klingeborn M, Striebel J, Dorward D, McGovern G, Jeffrey M.

PLoS Pathog. 2010 Mar 5;6(3):e1000800. doi: 10.1371/journal.ppat.1000800.

18.

Genetic and infectious prion diseases.

Prusiner SB.

Arch Neurol. 1993 Nov;50(11):1129-53. Review.

PMID:
8105771
20.

Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis.

Buhler LA, Samara R, Guzman E, Wilson CL, Krizanac-Bengez L, Janigro D, Ethell DW.

BMC Neurosci. 2009 Mar 6;10:17. doi: 10.1186/1471-2202-10-17.

Supplemental Content

Support Center